Why ERNA? Ernexa Therapeutics Inc. Analysis, Price & AI Insights | Whystock
ERNA
$0.15+0.00 (+3.32%)
Market ClosedLast close May 1
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease.